Literature DB >> 9834843

Emerging roles for PAX transcription factors in cancer biology.

B W Schäfer1.   

Abstract

Pax genes are transcription factors which act as essential control genes during the establishment of embryonic cell lineages. Recent evidence now demonstrates that their expression is deregulated by different mechanisms in several tumor types including Wilms' tumors, rhabdomyosarcomas, brain tumors and lymphomas. The oncogenic role of PAX proteins in tumor development is now subject of intensive investigations and may include stimulation of the rate of proliferation as well as inhibition of the apoptotic program. In addition, the expression of PAX genes in these cancers might serve as a diagnostic and probably also prognostic tool.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834843

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  10 in total

1.  Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis.

Authors:  Paulette Mhawech-Fauceglia; Rhakee Saxena; Shaozeng Zhang; Luigi Terracciano; Guido Sauter; Arundhuti Chadhuri; Francois R Herrmann; Remedios Penetrante
Journal:  J Clin Pathol       Date:  2006-07-12       Impact factor: 3.411

Review 2.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.

Authors:  Yinlong Ren; Junna Hou; Aiguo Xu; Yunbao Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Qiuping Dong; Yachao Hou; Jun Yu; Daiming Fan; Xishan Hao
Journal:  Oncotarget       Date:  2014-09-15

5.  Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5.

Authors:  Xu Lu; Chao Yang; Yuanchang Hu; Jian Xu; Chengyu Shi; Jianhua Rao; Weixin Yu; Feng Cheng
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

6.  Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.

Authors:  Weiguo Han; Tao Wang; Andrew A Reilly; Steven M Keller; Simon D Spivack
Journal:  Respir Res       Date:  2009-09-25

7.  Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.

Authors:  Patrícia Patrício; João Ramalho-Carvalho; Pedro Costa-Pinheiro; Mafalda Almeida; João Diogo Barros-Silva; Joana Vieira; Paula Cristina Dias; Francisco Lobo; Jorge Oliveira; Manuel R Teixeira; Rui Henrique; Carmen Jeronimo
Journal:  J Cell Mol Med       Date:  2013-07-26       Impact factor: 5.310

8.  Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma.

Authors:  Yu-Lueng Shih; Chih-Chi Kuo; Ming-De Yan; Ya-Wen Lin; Chung-Bao Hsieh; Tsai-Yuan Hsieh
Journal:  Clin Epigenetics       Date:  2016-04-22       Impact factor: 6.551

9.  PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.

Authors:  Wei Liu; Fang Sui; Jiazhe Liu; Meichen Wang; Sijia Tian; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Oncotarget       Date:  2016-08-23

10.  Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.

Authors:  Gwan Hee Han; Doo Byung Chay; Sanghee Nam; Hanbyoul Cho; Joon-Yong Chung; Jae-Hoon Kim
Journal:  BMC Cancer       Date:  2019-12-10       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.